In search of novel diagnostic and therapeutic tools, TSPO has gained interest recently, and earlier works could indeed show an association of tracer uptake on TSPO PET with IDH mutation status as a marker of glioma aggressiveness [24, 25]. The gene discussed is TSPO; the disease is glioma.